Evidence map›Paper›PMID 29038773›Full record

Article3 Biotech2017

A fusion protein strategy for soluble expression of

Liangliang Chen, Ping Sun, Yan Li, Ming Yan, Lin Xu, Kequan Chen, Pingkai Ouyang

Open access · greenAbstract read
In one paragraph

Article in 3 Biotech, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. The progress on stevia (Frontiers in nutrition · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Liangliang ChenCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Ping SunCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Yan LiCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Ming YanCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Lin XuCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Kequan ChenCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Pingkai OuyangCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, 211800 China.
Nanjing Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The UDP-glucosyltransferase UGT76G1 from

Indexed as

Fusion partnerGlucosyltransferaseInclusion bodyRebaudioside ASteviosideUGT76G1

Identifiers

PMID29038773
PMCPMC5624807
OpenAlexW2763291867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.